Literature DB >> 33788265

The link between microglia and the severity of COVID-19: The "two-hit" hypothesis.

Jaouad Bouayed1, Torsten Bohn2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33788265     DOI: 10.1002/jmv.26984

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


× No keyword cloud information.
  5 in total

Review 1.  Liposome encapsulated clodronate mediated elimination of pathogenic macrophages and microglia: A promising pharmacological regime to defuse cytokine storm in COVID-19.

Authors:  Sowbarnika Ravichandran; Nivethitha Manickam; Mahesh Kandasamy
Journal:  Med Drug Discov       Date:  2022-06-13

Review 2.  COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes.

Authors:  Banafsheh Bigdelou; Mohammad Reza Sepand; Sahar Najafikhoshnoo; Jorge Alfonso Tavares Negrete; Mohammed Sharaf; Jim Q Ho; Ian Sullivan; Prashant Chauhan; Manina Etter; Tala Shekarian; Olin Liang; Gregor Hutter; Rahim Esfandiarpour; Steven Zanganeh
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

Review 3.  SARS-CoV-2 involvement in central nervous system tissue damage.

Authors:  Muhammad Ali Haidar; Zaynab Shakkour; Mohammad Amine Reslan; Nadine Al-Haj; Perla Chamoun; Karl Habashy; Hasan Kaafarani; Shima Shahjouei; Sarah H Farran; Abdullah Shaito; Esber S Saba; Bassam Badran; Mirna Sabra; Firas Kobeissy; Maya Bizri
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

Review 4.  Can exercise attenuate the negative effects of long COVID syndrome on brain health?

Authors:  Wei-Peng Teo; Alicia M Goodwill
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

5.  Oxidative stress status and vitamin D levels of asymptomatic to mild symptomatic COVID-19 infections during the third trimester of pregnancy: A retrospective study in Metz, France.

Authors:  Guillaume Schmitt; Sary Labdouni; Rachid Soulimani; Catherine Delamare; Jaouad Bouayed
Journal:  J Med Virol       Date:  2022-01-27       Impact factor: 20.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.